Yunnan Hongxiang Yixintang (002727) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yunnan Hongxiang Yixintang (002727) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥527.92 Million ≈ $77.25 Million USD) by net assets (CN¥7.47 Billion ≈ $1.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yunnan Hongxiang Yixintang (002727) net asset quality to measure how much of total assets are equity-financed.
Yunnan Hongxiang Yixintang - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Yunnan Hongxiang Yixintang's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Yunnan Hongxiang Yixintang (002727) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Yunnan Hongxiang Yixintang Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yunnan Hongxiang Yixintang ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanjing Sciyon Automation Group Co Ltd
SHE:002380
|
0.148x |
|
CRA International Inc
NASDAQ:CRAI
|
-0.574x |
|
Kinh Bac City Development Share Holding Corp
VN:KBC
|
-0.106x |
|
POSCO-Thainox Public Company Limited
BK:INOX
|
-0.040x |
|
Drägerwerk AG & Co. KGaA
XETRA:DRW8
|
0.050x |
|
Elco Ltd
TA:ELCO
|
-0.042x |
|
Daktronics Inc
NASDAQ:DAKT
|
0.040x |
|
Omada Health, Inc. Common Stock
NASDAQ:OMDA
|
0.047x |
Annual Cash Flow Conversion Efficiency for Yunnan Hongxiang Yixintang (2009–2025)
The table below shows the annual cash flow conversion efficiency of Yunnan Hongxiang Yixintang from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 002727 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
CN¥1.63 Billion ≈ $239.02 Million |
0.219x | -2.57% |
| 2024-12-31 | CN¥7.65 Billion ≈ $1.12 Billion |
CN¥1.72 Billion ≈ $251.77 Million |
0.225x | -16.29% |
| 2023-12-31 | CN¥7.88 Billion ≈ $1.15 Billion |
CN¥2.12 Billion ≈ $309.54 Million |
0.269x | -19.05% |
| 2022-12-31 | CN¥7.53 Billion ≈ $1.10 Billion |
CN¥2.50 Billion ≈ $365.40 Million |
0.332x | +23.54% |
| 2021-12-31 | CN¥6.67 Billion ≈ $976.40 Million |
CN¥1.79 Billion ≈ $262.18 Million |
0.269x | +50.20% |
| 2020-12-31 | CN¥5.78 Billion ≈ $845.87 Million |
CN¥1.03 Billion ≈ $151.21 Million |
0.179x | -16.41% |
| 2019-12-31 | CN¥4.60 Billion ≈ $672.56 Million |
CN¥982.92 Million ≈ $143.83 Million |
0.214x | +36.22% |
| 2018-12-31 | CN¥4.05 Billion ≈ $592.57 Million |
CN¥635.77 Million ≈ $93.03 Million |
0.157x | +48.26% |
| 2017-12-31 | CN¥3.69 Billion ≈ $540.54 Million |
CN¥391.16 Million ≈ $57.24 Million |
0.106x | +37.32% |
| 2016-12-31 | CN¥2.50 Billion ≈ $365.55 Million |
CN¥192.63 Million ≈ $28.19 Million |
0.077x | -5.65% |
| 2015-12-31 | CN¥2.27 Billion ≈ $332.61 Million |
CN¥185.76 Million ≈ $27.18 Million |
0.082x | -3.41% |
| 2014-12-31 | CN¥2.08 Billion ≈ $304.77 Million |
CN¥176.22 Million ≈ $25.79 Million |
0.085x | -61.07% |
| 2013-12-31 | CN¥1.05 Billion ≈ $153.67 Million |
CN¥228.22 Million ≈ $33.40 Million |
0.217x | +11.76% |
| 2012-12-31 | CN¥810.77 Million ≈ $118.64 Million |
CN¥157.67 Million ≈ $23.07 Million |
0.194x | +20.41% |
| 2011-12-31 | CN¥628.80 Million ≈ $92.01 Million |
CN¥101.55 Million ≈ $14.86 Million |
0.162x | -24.85% |
| 2010-12-31 | CN¥497.43 Million ≈ $72.79 Million |
CN¥106.90 Million ≈ $15.64 Million |
0.215x | +2.05% |
| 2009-12-31 | CN¥262.78 Million ≈ $38.45 Million |
CN¥55.34 Million ≈ $8.10 Million |
0.211x | -- |
About Yunnan Hongxiang Yixintang
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, sanitary products and disposable medical products, household appliances, adult toys, agricultura… Read more